Skip to main content
NCBI home page
Sarcoma logoLink to Sarcoma
. 1997 Dec;1(3-4):161–165. doi: 10.1080/13577149778254

A Retrospective Clinicopathological Study of 37 Patients With Chordoma: A Danish National Series

Akmal Safwat 1, Ole S Nielsen 1,4,✉, Anne G Jurik 1, Johnny Keller 1, Ernst R Weeth 2, Bjarne Lund 3, Olaf Myhre-Jensen 1
PMCID: PMC2395368  PMID: 18521219

Abstract

Purpose. There are, in general, few published series on chordoma. It is a rare disease and further data are still needed.

Patients/methods. The data of 37 patients with chordoma were retrospectively analyzed. Treatment was surgical excision in 11, radical radiotherapy in 9 and a combination of the two in 16 cases. The male to female ratio was 2.7 : 1. Median age was 59 years (range 1–89 years).

Results. The most common symptoms at diagnosis were pain (98%), neurological disturbances (42%) and incontinence (33%). The tumours were located in the sacro-coccygeal region in 68%, the spheno-occipital region in 16% and the vertebrae in 16% of the patients. Median tumour.size was 7 cm (range 1–30 cm). Local recurrence occurred in 21/36 treated cases and distant metastases developed in eight patients (23%). The median time to recurrence/progression after primary treatment was 2 years (range 1–10 years). The actuarial 5-year rates of overall, progression-free and symptom-free survival were 40%, 31% and 20%, respectively. The corresponding 10-year rates were 26%, 21% and 14%, respectively. At the time of analysis, seven patients were alive, six without evidence of disease. Four of the six patients without active disease were symptom free. A univariate analysis showed that age, sex, tumour size, histopathology, surgical safety margin, treatment modality and radiation dose did not significantly affect overall, progression-free or symptom-free survival. Only turnout site had a prognostic value with turnouts in the spheno-occipital region carrying the worst prognosis.

Discussion. We conclude that effective treatment against chordomas is still lacking and a prospective multi-institutional registration study may provide more information on the optimal work-up and treatment of this rare disease.

Full Text

The Full Text of this article is available as a PDF (445.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bethke K. P., Neifeld J. P., Lawrence W., Jr Diagnosis and management of sacrococcygeal chordoma. J Surg Oncol. 1991 Dec;48(4):232–238. doi: 10.1002/jso.2930480405. [DOI] [PubMed] [Google Scholar]
  2. Bjornsson J., Wold L. E., Ebersold M. J., Laws E. R. Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer. 1993 Feb 1;71(3):735–740. doi: 10.1002/1097-0142(19930201)71:3<735::aid-cncr2820710314>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  3. Castro J. R., Linstadt D. E., Bahary J. P., Petti P. L., Daftari I., Collier J. M., Gutin P. H., Gauger G., Phillips T. L. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):647–655. doi: 10.1016/0360-3016(94)90550-9. [DOI] [PubMed] [Google Scholar]
  4. Cummings B. J., Esses S., Harwood A. R. The treatment of chordomas. Cancer Treat Rev. 1982 Dec;9(4):299–311. doi: 10.1016/s0305-7372(82)80042-x. [DOI] [PubMed] [Google Scholar]
  5. Cummings B. J., Hodson D. I., Bush R. S. Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys. 1983 May;9(5):633–642. doi: 10.1016/0360-3016(83)90228-6. [DOI] [PubMed] [Google Scholar]
  6. Eriksson B., Gunterberg B., Kindblom L. G. Chordoma. A clinicopathologic and prognostic study of a Swedish national series. Acta Orthop Scand. 1981 Feb;52(1):49–58. doi: 10.3109/17453678108991758. [DOI] [PubMed] [Google Scholar]
  7. Jacob H. E. Chemotherapy for cranial base tumors. J Neurooncol. 1994;20(3):327–335. doi: 10.1007/BF01053047. [DOI] [PubMed] [Google Scholar]
  8. Keisch M. E., Garcia D. M., Shibuya R. B. Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg. 1991 Sep;75(3):374–377. doi: 10.3171/jns.1991.75.3.0374. [DOI] [PubMed] [Google Scholar]
  9. Magrini S. M., Papi M. G., Marletta F., Tomaselli S., Cellai E., Mungai V., Biti G. Chordoma-natural history, treatment and prognosis. The Florence Radiotherapy Department experience (1956-1990) and a critical review of the literature. Acta Oncol. 1992;31(8):847–851. doi: 10.3109/02841869209089717. [DOI] [PubMed] [Google Scholar]
  10. Mitchell A., Scheithauer B. W., Unni K. K., Forsyth P. J., Wold L. E., McGivney D. J. Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer. 1993 Nov 15;72(10):2943–2949. doi: 10.1002/1097-0142(19931115)72:10<2943::aid-cncr2820721014>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  11. O'Connell J. X., Renard L. G., Liebsch N. J., Efird J. T., Munzenrider J. E., Rosenberg A. E. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer. 1994 Oct 15;74(8):2261–2267. doi: 10.1002/1097-0142(19941015)74:8<2261::aid-cncr2820740809>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  12. Saxton J. P. Chordoma. Int J Radiat Oncol Biol Phys. 1981 Jul;7(7):913–915. doi: 10.1016/0360-3016(81)90008-0. [DOI] [PubMed] [Google Scholar]
  13. Schoedel K. E., Martinez A. J., Mahoney T. M., Contis L., Becich M. J. Chordomas: pathological features; ploidy and silver nucleolar organizing region analysis. A study of 36 cases. Acta Neuropathol. 1995;89(2):139–143. doi: 10.1007/BF00296357. [DOI] [PubMed] [Google Scholar]
  14. Tai P. T., Craighead P., Bagdon F. Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques. Cancer. 1995 Feb 1;75(3):749–756. doi: 10.1002/1097-0142(19950201)75:3<749::aid-cncr2820750302>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  15. Thieblemont C., Biron P., Rocher F., Bouhour D., Bobin J. Y., Gérard J. P., Blay J. Y. Prognostic factors in chordoma: role of postoperative radiotherapy. Eur J Cancer. 1995 Dec;31A(13-14):2255–2259. doi: 10.1016/0959-8049(95)00458-0. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES